Evidence map›Paper›PMID 23643458›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2014

Evaluation of memory endophenotypes for association with CLU, CR1, and PICALM variants in black and white subjects.

Otto Pedraza, Mariet Allen, Kyle Jennette, Minerva Carrasquillo, Julia Crook, Daniel Serie, V Shane Pankratz, Ryan Palusak, Thuy Nguyen, Kimberly Malphrus and 10 more

Abstract read
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 2 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 2 syntheses or guidelines pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Frontiers in genetics · 2021
    Article
  10. Longitudinal analysis ofJournal of genetics · 2021
    Article
  11. Review
  12. Review
  13. Article
  14. Genome-wide association study of Alzheimer's disease endophenotypes at prediagnosis stages.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2018
    Article
  15. Article
  16. Review
  17. Peripheral complement interactions with amyloid β peptide: Erythrocyte clearance mechanisms.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2017
    Article
  18. Genetic variants associated with risk of Alzheimer's disease contribute to cognitive change in midlife: The Atherosclerosis Risk in Communities Study.American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics · 2017
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 4 institutions in 1 country.

Otto PedrazaMayo Clinic Florida, Department of Psychiatry and Psychology, Jacksonville, FL, USA.
Mariet AllenMayo Clinic Florida, Department of Neuroscience, Jacksonville, FL, USA.
Kyle JennetteMayo Clinic Florida, Department of Neuroscience, Jacksonville, FL, USA.
Minerva CarrasquilloMayo Clinic Florida, Department of Neuroscience, Jacksonville, FL, USA.
Julia CrookMayo Clinic Florida, Biostatistics Unit, Jacksonville, FL, USA.
Daniel SerieMayo Clinic Florida, Biostatistics Unit, Jacksonville, FL, USA.
V Shane PankratzMayo Clinic Minnesota, Department of Biostatistics, Rochester, MN, USA.
Ryan PalusakMayo Clinic Florida, Department of Neuroscience, Jacksonville, FL, USA.
Thuy NguyenMayo Clinic Florida, Department of Neuroscience, Jacksonville, FL, USA.
Kimberly MalphrusMayo Clinic Florida, Department of Neuroscience, Jacksonville, FL, USA.
Li MaMayo Clinic Florida, Department of Neuroscience, Jacksonville, FL, USA.
Gina BisceglioMayo Clinic Florida, Department of Neuroscience, Jacksonville, FL, USA.
Rosebud O RobertsMayo Clinic Minnesota, Division of Epidemiology, Rochester, MN, USA.
John A LucasMayo Clinic Florida, Department of Psychiatry and Psychology, Jacksonville, FL, USA.
Robert J IvnikMayo Clinic Minnesota, Department of Psychiatry and Psychology, Rochester, MN, USA.
Glenn E SmithMayo Clinic Minnesota, Department of Psychiatry and Psychology, Rochester, MN, USA.
Neill R Graff-RadfordMayo Clinic Florida, Department of Neurology, Jacksonville, FL, USA.
Ronald C PetersenMayo Clinic Minnesota, Department of Neurology, Rochester, MN, USA.
Steven G YounkinMayo Clinic Florida, Department of Neuroscience, Jacksonville, FL, USA.
Nilüfer Ertekin-TanerMayo Clinic Florida, Department of Neuroscience, Jacksonville, FL, USA; Mayo Clinic Florida, Department of Neurology, Jacksonville, FL, USA. Electronic address: taner.nilufer@mayo.edu.
Jacksonville College · USMayo Clinic in Florida · USMayo Clinic · USMayo Clinic in Arizona · US

Funding

SUPPLEMENT TO ALZHEIMERS DISEASE PATIENT REGISTRYU01AG006786 · NIA · MAYO CLINIC ROCHESTER · PI GRAFF-RADFORD, JONATHAN, JACK, CLIFFORD R. · 1986 to 2023
$49.6M
THE PGRN/TDP-43 AXIS IN ALZHEIMER?S DISEASE AND NEURODEGENERATIONP50AG016574 · NIA · MAYO CLINIC ROCHESTER · PI LUCAS, JOHN · 1999 to 2018
$36.9M
PLASMA A BETA AS A SURROGATE GENETIC MARKER FOR LOADR01AG018023 · NIA · MAYO CLINIC JACKSONVILLE · PI YOUNKIN, STEVEN G · 2001 to 2012
$3.3M
Gene discovery in PSP by transcriptome, neuropathology and sequence analysisR01NS080820 · NINDS · MAYO CLINIC JACKSONVILLE · PI ERTEKIN-TANER, NILUFER · 2013 to 2017
$1.8M
Genome wide association study of gene expression levels in Alzheimer's diseaseR01AG032990 · NIA · MAYO CLINIC JACKSONVILLE · PI ERTEKIN-TANER, NILUFER · 2009 to 2011
$932k
Vascular /Inflammatory Predictors of MCI Risk /ProgressiK01AG028573 · NIA · MAYO CLINIC ROCHESTER · PI ROBERTS, ROSEBUD O · 2006 to 2008
$351k
NIA NIH HHS K01 AG028573NIA NIH HHS P50 AG016574NIA NIH HHS R01 AG018023NIA NIH HHS R01 AG032990NIA NIH HHS U01 AG006786NINDS NIH HHS R01 NS080820
6 · The paper itself

Abstract

backgroundGenetic variants at the CLU, CR1, and PICALM loci associate with risk for late-onset Alzheimer's disease (LOAD) in genomewide association studies. In this study, our aim was to determine whether the LOAD risk variants at these three loci influence memory endophenotypes in black and white subjects.

methodsWe pursued an association study between single nucleotide polymorphism genotypes at the CLU, CR1, and PICALM loci and memory endophenotypes. We assessed black subjects (AA series: 44 with LOAD and 224 control subjects) recruited at Mayo Clinic Florida and whites recruited at Mayo Clinic Minnesota (RS series: 372 with LOAD and 1690 control subjects) and Florida (JS series: 60 with LOAD and 529 control subjects). Single nucleotide polymorphisms at the LOAD risk loci CLU (rs11136000), CR1 (rs6656401, rs3818361), and PICALM (rs3851179) were genotyped and tested for association with Logical Memory immediate recall, Logical Memory delayed recall, Logical Memory percent retention, Visual Reproduction immediate recall, Visual Reproduction delayed recall, and Visual Reproduction percent retention scores from the Wechsler Memory Scale-Revised using multivariable linear regression analysis, adjusting for age at exam, sex, education, and apolipoprotein E ε4 dosage.

resultsWe identified nominally significant or suggestive associations between the LOAD-risky CR1 variants and worse Logical Memory immediate recall scores in blacks (P = .068-.046, β = -2.7 to -1.2). The LOAD-protective CLU variant is associated with better logical memory endophenotypes in white subjects (P = .099-.027, β = 0.31-0.93). The CR1 associations persisted when the control subjects from the AA series were assessed separately. The CLU associations appeared to be driven by one of the white series (RS) and were also observed when the control subset from RS was analyzed.

conclusionThese results suggest for the first time that LOAD risk variants at CR1 may influence memory endophenotypes in blacks. In addition, the CLU LOAD-protective variant may confer enhanced memory in whites. Although these results would not remain significant after stringent corrections for multiple testing, they need to be considered in the context of the LOAD associations with which they have biological consistency. They also provide estimates for effect sizes on memory endophenotypes that could guide future studies. The detection of memory effects for these variants in clinically normal subjects, implies that these LOAD risk loci might modify memory prior to clinical diagnosis of AD.

Indexed as

AgedAged, 80 and overAlzheimer DiseaseApolipoprotein E4Black PeopleClusterinEndophenotypesFemaleGenetic Association StudiesGenetic Predisposition to DiseaseHumansMaleMemoryMiddle AgedMonomeric Clathrin Assembly ProteinsPolymorphism, Single NucleotideApolipoprotein E4CLU protein, humanClusterinCR1 protein, humanMonomeric Clathrin Assembly ProteinsPICALM protein, humanReceptors, Complement 3bAlzheimer's diseaseAssociationCLUCR1EndophenotypesGeneticMemoryPICALM

Identifiers

PMID23643458
PMCPMC3815516
OpenAlexW1989069798

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.